Movement Disorders and Its Variants

IF 3 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

PET Clinics Pub Date : 2024-10-29 DOI:10.1016/j.cpet.2024.09.012

Anne-Sophie Salabert PhD, Pharm , Pierre Payoux PhD, MD

引用次数: 0

查看原文本刊更多论文

运动障碍及其变异。

自 2000 年代以来，核医学主要使用 DaTSCAN SPECT 和 [18F]-FDG PET 来研究运动障碍。PET 放射性示踪剂的最新进展，如用于多巴胺转运体的 LBT 999 和用于 tau 病的 tau 示踪剂（如 flortaucipir），正在提高诊断的精确性。其他 PET 示踪剂针对神经炎症、突触密度、胆碱能功能和腺苷 A2A 受体。[18F]-ROStrace等新型工具有助于检测神经退行性疾病中的氧化应激。这些发展有望在探索运动障碍病理的过程中改善患者管理、缩短检查时间并提高诊断准确性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

PET Clinics RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-

CiteScore

5.70

自引率

3.80%

发文量

期刊介绍： As the clinical applications of positron emission tomography (PET) increase, the new PET Clinics brings together the combined expertise of leading authorities in the field to provide you incisive clinical reviews on advances in the use of PET and combined PET/CT. Published quarterly, PET Clinics provides concise, practical guidance on the clinical issues you face every day. It examines PET is effectiveness in cancer diagnosis and staging, as well as exploring PET is usefulness in the areas of dementia, myocardial viability, and other conditions. Full-color images featured throughout. Topics covered include Breast Cancer, Alzheimer is Disease and Dementia, Lymphoma, Lung Cancer, Cardiology, Pediatric Applications, Infection and Inflammation.